Skip to content

Clinical trials

Phase 1 Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Phase 1 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20092
20101
20114
20125
20143
20152
20161
20171
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ViiV Healthcare4
Gilead Sciences3
Eiger BioPharmaceuticals2
GlaxoSmithKline2
Tibotec BVBA2
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1
Boryung Pharmaceutical Co., Ltd1
Christopher O'Brien, MD1
Dynavax Technologies Corporation1
GlobeImmune1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis24
Hepatitis C7
Hepatitis B5
Acquired Immunodeficiency Syndrome4
Infections4
Hepatitis B, Chronic2
Adenoviridae Infections1
Fibrosis1
Hepatitis D1
Hepatitis, Alcoholic1

Trials

Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.